Arkolith/Insider Trading/CINC/Form 4

CinRx Pharma, LLC

10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Jan 13, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)1.2M——3.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)2.0M—$00
Jan 11, 2022Conversion(C)2.1M—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-003200) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML